Vestal Point Capital, LP

Position in AVR — Anteris Technologies Global Corp.

CIK 1974915 NEW YORK, NY

Position in AVR

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$6,353,529

New position

Shares Held

1,144,780

first reported quarter

Ownership

1.18%

of shares outstanding

% of Portfolio

0.18%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Vestal Point Capital, LP holds $196,951,519 across 5 Medical Instruments & Supplies names. AVR ranks #4 (3.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RGEN	Repligen Corp	925,000	$108,983,500
2	ALC	Alcon Inc	800,000	$60,280,000
3	WST	West Pharmaceutical Services Inc	75,000	$18,798,000
4	AVR	Anteris Technologies Global Corp. This page	1,144,780	$6,353,529
5	NYXH	Nyxoah SA	868,661	$2,536,490

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$6,353,529	1,144,780	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.